Different body mass indexes and their relation to prognosis of early-stage breast cancer in postmenopausal Mexican-Mestizo women

References

• Ayoub, N. M., R. J. Yaghan, N. M. Abdo, I. I. Matalka, L. M. Akhu-Zaheya, and A. H. Al-Mohtaseb. 2019. Impact of obesity on clinicopathologic characteristics and disease prognosis in pre- and postmenopausal breast cancer patients: A retrospective institutional study. Journal of Obesity 2019:3820759. doi:10.1155/2019/3820759.
   PubMed Web of Science ®Google Scholar
• Banegas, M. P., and C. I. Li. 2012. Breast cancer characteristics and outcomes among hispanic black and hispanic white women. Breast Cancer Research and Treatment 134 (3):1297–304. doi:10.1007/s10549-012-2142-1.
   PubMed Web of Science ®Google Scholar
• Bekker-Mendez, C., J. K. Yamamoto-Furusho, G. Vargas-Alarcón, D. Ize-Ludlow, J. Alcocer-Varela, and J. Granados. 1998. Haplotype distribution of class II MHC genes in Mexican patients with systemic lupus erythematosus. Scandinavian Journal of Rheumatology 27 (5):373–76. doi:10.1080/03009749850154410.
   PubMed Web of Science ®Google Scholar
• Cancer Genome Atlas Network. 2012. Comprehensive molecular portraits of human breast tumours. Nature 490 (7418):61–70. doi:10.1038/nature11412.
   PubMed Web of Science ®Google Scholar
• Chan, D. S., A. R. Vieira, D. Aune, E. V. Bandera, D. C. Greenwood, A. McTiernan, D. Navarro Rosenblatt, I. Thune, R. Vieira, and T. Norat. 2014. Body mass index and survival in women with breast cancer-systematic literature review and meta-analysis of 82 follow-up studies. Annals of Oncology 25 (10):1901–14. doi:10.1093/annonc/mdu042.
   PubMed Web of Science ®Google Scholar
• Dai, X., Y. Li, Z. Bai, and X. Q. Tang. 2015. Molecular portraits revealing the heterogeneity of breast tumor subtypes defined using immunohistochemistry markers. Scientific Reports 5 (1):14499. doi:10.1038/srep14499.
   PubMedGoogle Scholar
• Encuesta Nacional de Salud y Nutrición (ENSANUT). 2018. México: Secretaría de Salud. México: Instituto Nacional de Salud Pública, Instituto Nacional de Estadística y Geografía. https://ensanut.insp.mx/.
   Google Scholar
• Gérard, C., and K. A. Brown. 2018. Obesity and breast cancer – Role of estrogens and the molecular underpinnings of aromatase regulation in breast adipose tissue. Molecular and Cellular Endocrinology 466:15–30. doi:10.1016/j.mce.2017.09.014.
   PubMed Web of Science ®Google Scholar
• Heng, Y. J., J. Wang, T. U. Ahearn, S. B. Brown, X. Zhang, C. B. Ambrosone, V. Piana de Andrade, A. M. Brufsky, F. J. Couch, T. A. King, et al. 2019. Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues. Breast Cancer Research and Treatment 173 (3):667–77. doi:10.1007/s10549-018-5034-1.
   PubMed Web of Science ®Google Scholar
• Horn, J., M. D. K. Alsaker, S. Opdahl, M. J. Engstrøm, S. Tretli, O. A. Haugen, A. M. Bofin, L. J. Vatten, and B. O. Asvold. 2014. Anthropometric factors and risk of molecular breast cancer subtypes among postmenopausal Norwegian women. International Journal of Cancer 135 (11):2678–86. doi:10.1002/ijc.28912.
   PubMed Web of Science ®Google Scholar
• Jiralerspong, S., E. S. Kim, W. Dong, L. Feng, G. N. Hortobagyi, and S. H. Giordano. 2013. Obesity, diabetes, and survival outcomes in a large cohort of early-stage breast cancer patients. Annals of Oncology 24 (10):2506–14. doi:10.1093/annonc/mdt224.
   PubMed Web of Science ®Google Scholar
• Kamineni, A., M. L. Anderson, E. White, S. H. Taplin, P. Porter, R. Ballard-Barbash, K. Malone, and D. S. Buist. 2013. Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population. Cancer Causes & Control: CCC 24 (2):305–12. doi:10.1007/s10552-012-0115-7.
   PubMed Web of Science ®Google Scholar
• Kerlikowske, K., R. Walker, D. L. Miglioretti, A. Desai, R. Ballard-Barbash, and D. S. Buist. 2008. Obesity, mammography use and accuracy, and advanced breast cancer risk. Journal of the National Cancer Institute 100(23):1724–33. doi:10.1093/jnci/djn388
   PubMedGoogle Scholar
• Kyndi, M., F. B. Sørensen, H. Knudsen, M. Overgaard, H. M. Nielsen, and J. Overgaard. 2008. Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: The danish breast cancer cooperative group. Journal of Clinical Oncology 26 (9):1419–26. doi:10.1200/JCO.2007.14.5565.
   PubMed Web of Science ®Google Scholar
• Le Doussal, V., M. Tubiana-Hulin, S. Friedman, K. Hacene, F. Spyratos, and M. Brunet. 1989. Prognostic value of histologic grade nuclear components of Scarff-Bloom-Richardson (SBR). An improved score modification based on a multivariate analysis of 1262 invasive ductal breast carcinomas. Cancer 64 (9):1914–21. doi:10.1002/1097-0142(19891101)64:9<914::aid-cncr2820640926>3.0.co;2-g.
   PubMed Web of Science ®Google Scholar
• Lisker, R., E. Ramirez, R. Perez-Briceño, J. Granados, and V. Babinsky. 1990. Gene frequencies and admixture estimates in four Mexican urban centers. Human Biology 62 (6):791–801.
   PubMed Web of Science ®Google Scholar
• Liu, Y. L., A. Saraf, B. Catanese, S. M. Lee, Y. Zhang, E. P. Connolly, and K. Kalinsky. 2018. Obesity and survival in the neoadjuvant breast cancer setting: Role of tumor subtype in an ethnically diverse population. Breast Cancer Research and Treatment 167 (1):277–88. doi:10.1007/s10549-017-4507-y.
   PubMed Web of Science ®Google Scholar
• Martínez-Ramírez, M., R. M. Coral-Vázquez, A. Tenorio, J. P. Méndez, J. Benítez-Granados, A. Maffuz Asis, S. Rodríguez Cuevas, C. Domínguez Reyes, A. Erazo-Valle, and P. Canto. 2018. Complete sequence of the ATP6 and ND3 mitochondrial genes in breast cancer tissue of postmenopausal women with different body mass indexes. Annals of Diagnostic Pathology 32:23–27. doi:10.1016/j.anndiagpath.2017.09.001.
   PubMed Web of Science ®Google Scholar
• Moolgavkar, S. H., N. E. Day, and R. G. Stevens. 1980. Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. Journal of the National Cancer Institute 65 (3):559–69.
   PubMed Web of Science ®Google Scholar
• Morris, P. G., C. A. Hudis, D. Giri, M. Morrow, D. J. Falcone, X. K. Zhou, B. Du, E. Brogi, C. B. Crawford, K. L. Kopelovich, et al. 2011. Inflammation and increased aromatase expression occur in the breast tissue of obese women with breast cancer. Cancer Prevention Research 4 (7):1021–29. doi:10.1158/1940-6207.CAPR-11-0110.
   PubMed Web of Science ®Google Scholar
• Ooi, S. L., M. E. Martinez, and C. I. Li. 2011. Disparities in breast cancer characteristics and outcomes by race/ethnicity. Breast Cancer Research and Treatment 127 (3):729–38. doi:10.1007/s10549-010-1191-6.
   PubMed Web of Science ®Google Scholar
• Renehan, A. G., M. Tyson, M. Egger, R. F. Heller, and M. Zwahlen. 2008. Body-mass index and incidence of cancer: A systematic review and meta-analysis of prospective observational studies. Lancet 371 (9612):569–78. doi:10.1016/S0140-6736(08)60269-X.
   PubMed Web of Science ®Google Scholar
• Rezende, L. F. M., M. Arnold, F. M. Rabacow, R. B. Levy, R. M. Claro, E. Giovannucci, and J. Eluf-Neto. 2018. The increasing burden of cancer attributable to high body mass index in Brazil. Cancer Epidemiology 54:63–70. doi:10.1016/j.canep.2018.03.006.
   PubMed Web of Science ®Google Scholar
• Sflomos, G., V. Dormoy, T. Metsalu, R. Jeitziner, L. Battista, V. Scabia, W. Raffoul, J. F. Delaloye, A. Treboux, M. Fiche, et al. 2016. A preclinical model for ERα-positive breast cancer points to the epithelial microenvironment as determinant of luminal phenotype and hormone response. Cancer Cell 29 (3):407–22. doi:10.1016/j.ccell.2016.02.002.
   PubMed Web of Science ®Google Scholar
• Sopik, V., P. Sun, and S. A. Narod. 2017. The prognostic effect of estrogen receptor status differs for younger versus older breast cancer patients. Breast Cancer Research and Treatment 165 (2):391–402. doi:10.1007/s10549-017-4333-2.
   PubMed Web of Science ®Google Scholar
• Sun, L., Y. Zhu, Q. Qian, and L. Tang. 2018. Body mass index and prognosis of breast cancer: An analysis by menstruation status when breast cancer diagnosis. Medicine (Baltimore) 97 (26):e11220. doi:10.1097/MD.0000000000011220.
   PubMed Web of Science ®Google Scholar
• Suzuki, R., N. Orsini, S. Saji, T. J. Key, and A. Wolk. 2009. Body weight and incidence of breast cancer defined by estrogen and progesterone receptor status—a meta-analysis. International Journal of Cancer 124 (3):698–712. doi:10.1002/ijc.23943.
   PubMed Web of Science ®Google Scholar
• Wang, X., T. L. Hui, M. Q. Wang, H. Liu, R. Y. Li, and Z. C. Song. 2019. Body mass index at diagnosis as a prognostic factor for early-stage invasive breast cancer after surgical resection. Oncology Research and Treatment 42 (4):195–201. doi:10.1159/000496548.
   PubMed Web of Science ®Google Scholar
• Warner, E. T., K. V. Ballman, C. Strand, J. C. Boughey, A. U. Buzdar, L. A. Carey, W. M. Sikov, and A. H. Partridge. 2016. Impact of race, ethnicity, and BMI on achievement of pathologic complete response following neoadjuvant chemotherapy for breast cancer: A pooled analysis of four prospective Alliance clinical trials (A151426). Breast Cancer Research and Treatment 159 (1):109–18. doi:10.1007/s10549-016-3918-5.
   PubMed Web of Science ®Google Scholar